WELCOME TO THE MANUFACTURING REPORT
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
| March 31, 2016
Future Market Insights has announced the addition of the “Manufacturing Execution Systems (MES) Market: Asia Pacific Industry Analysis and Opportunity Assessment 2014 - 2020" report to their offering.
Manufacturing execution system (MES), as the name suggests, it’s a computerized system, which can be implemented in the manufacturing process, to increase manufacturing efficiency and accuracy. It manages and monitors work in process on a factory floor. The goals of MES are to make the manufacturi...
FMI | March 07, 2018
FMI Instrumed, Schiedam, the Netherlands, has added a fifth metal Additive Manufacturing system to its existing facilities for the production of medical devices. “The increasing contribution of Additive Manufacturing in the medical device industry endorses further developments within our company,” explained Henk Jansen, FMI Instrumed’s Managing Director. Currently, the company uses metal AM to produce devices such as spinal implants, titanium hip cups and knee implants. “...
Keppel Offshore & Marine, Lloyd's Register | January 14, 2020
Keppel Offshore & Marine has received Lloyd’s Register LR Certification to additively manufacture offshore grade steel with a 3D printing technology from Singapore Institute of Manufacturing Technology SIMTech. The certification was granted after assessing Keppel O&M’s production processes, from design to post-processing and testing. Partnering with Nanyang Technological University, Singapore NTU Singapore and SIMTech’s Agency for Science, Technology and Research A*STAR...
Outsourcing-Pharma.com | January 13, 2020
BMS and Catalent disclosed the deal for the site in June, at which time they hoped to work through the regulatory approvals and union consultations needed to close the transaction by the end of the year. One week into 2020, Bristol-Myers revealed it had closed the deal. The deal covers a 19,300-square-meter manufacturing facility in Anagni, a town in central Italy, that lists cardiovascular, neuroleptics, anticancer, metabolic and anti-inflammatory medicines among the drugs it makes and packages...
Innovation, Industrial 4.0
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE